CLO James Burns sells 21,752 shares at $52.21 avg; reduces holdings 58.1% to 15.7K shares
James William Burns, Chief Legal Officer of Agios Pharmaceuticals, executed two separate sales on 2024-11-07, selling 13,411 shares at $52.00 and 8,341 shares at $52.56 for a combined $1,135,774.96. This represents a substantial 58.1% reduction in his post-transaction holdings, bringing them from 37,452 shares to 15,700 shares. The sale occurs in a context of significant recent stock appreciation—the company has posted +38.4% returns over the prior 30 days and +32.1% over 90 days, while the stock currently trades at $59.02, well above the transaction prices. Against the backdrop of AGIO's exceptional financial momentum (annual revenue growth of +88.4%, net income of $947,915,000.00 despite prior-year unprofitability), a large equity reduction by a senior officer merits investor scrutiny into whether this reflects personal portfolio considerations or other material factors.